Mainstream

Basilea Pharmaceutica AG GAAP EPS of CHF 1.26, revenue of CHF 104M; updates FY outlook

Basilea Pharmaceutica AG GAAP EPS of CHF 1.26, revenue of CHF 104M; updates FY outlook

Post ContentbpmufRead More

You might also be interested in reading Saylor: Strategy Investors Should Hold MSTR for 7 to 10 Years.

August 19, 2025
In Mainstream